|
64
|
244
|
6hw6B |
Yeast 20s proteasome in complex with 20 |
|
57
|
222
|
6hv4L |
Yeast 20s proteasome with human beta2i (1-53) in complex with onx 0914 |
|
68
|
250
|
6hw6A |
Yeast 20s proteasome in complex with 20 |
|
55
|
222
|
6hw4H |
Yeast 20s proteasome in complex with 16 |
|
62
|
195
|
6hw7J |
Yeast 20s proteasome in complex with 29 |
|
69
|
212
|
6hw6K |
Yeast 20s proteasome in complex with 20 |
|
72
|
243
|
6hw6F |
Yeast 20s proteasome in complex with 20 |
|
69
|
243
|
5l5bF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
|
69
|
242
|
5l5dD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
44
|
196
|
3uneJ |
Mouse constitutive 20s proteasome |
|
59
|
201
|
3unhK |
Mouse 20s immunoproteasome |
|
67
|
233
|
6gopM |
Yeast 20s proteasome in complex with homosalinosporamide a |
|
68
|
250
|
6hw7A |
Yeast 20s proteasome in complex with 29 |
|
45
|
213
|
5m32L |
Human 26s proteasome in complex with oprozomib |
|
62
|
241
|
5m2bG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
69
|
243
|
5m2bF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
40
|
234
|
5m32E |
Human 26s proteasome in complex with oprozomib |
|
60
|
195
|
5m2bJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
47
|
237
|
5m32G |
Human 26s proteasome in complex with oprozomib |
|
54
|
196
|
5lf3J |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
67
|
239
|
5lf1F |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
58
|
202
|
5lf6N |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
60
|
237
|
5lf0C |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
67
|
237
|
5lf7C |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
65
|
244
|
5lf7G |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
64
|
234
|
5le5E |
Native human 20s proteasome at 1.8 angstrom |
|
54
|
196
|
5lf0J |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
54
|
196
|
5lf1J |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
60
|
234
|
5lf7E |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
65
|
213
|
5lf0L |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
69
|
213
|
5lf7L |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
63
|
234
|
5lexE |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
59
|
202
|
5lf1N |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
65
|
244
|
5lf4G |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
68
|
213
|
5lf4L |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
63
|
233
|
5lf7D |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
63
|
244
|
5lf0G |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
61
|
234
|
5leyE |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
65
|
230
|
5lf3A |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
67
|
239
|
5leyF |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
64
|
239
|
5lf0F |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
70
|
239
|
5lf4F |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
61
|
220
|
5lf1H |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
62
|
244
|
5lf1G |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
67
|
216
|
5lf4M |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
54
|
196
|
5lezJ |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
53
|
204
|
5lf6I |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
53
|
204
|
5lf0I |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
66
|
216
|
5lf3M |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
66
|
200
|
5lf7K |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
